Bio-Rad Laboratories (BIO) Q4 2024 Annual Earnings
BIO·Reported February 13, 2025·After market close
Bio-Rad Laboratories reported Q4 2024 revenue of $667.5M, missed analyst consensus of $679.8M by $12.3M. Diluted EPS came in at $2.90, beat the $2.86 consensus by $0.04.
Revenue
$667.5Mmissed by $12.3M
Consensus: $679.8MDiluted EPS
$2.90beat by $0.04
Consensus: $2.86
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Bio-Rad Laboratories's Q4 2024 earnings report.
Bio-Rad Laboratories (BIO) reported Q4 2024 earnings on February 13, 2025 after market close.
Bio-Rad Laboratories reported revenue of $667.5M and diluted EPS of $2.90 for Q4 2024.
Revenue missed the consensus estimate of $679.8M by $12.3M. EPS beat the consensus estimate of $2.86 by $0.04.
You can read the 10-K periodic report (0000012208-25-000007) directly on SEC EDGAR. The filing index links above go to sec.gov.